ALMRO CLINICAL RESEARCH SOLUTIONS LTD

💤Zombieactive
11319906 · ltd · incorporated 2018-04-19
Investment thesis
Zombie company — trading but stalled; unlikely mover.
Why interesting: Quiet, steady; could be a succession or carve-out candidate with the right conversation.
Why risky: No growth signal; thin margin for error on price.
🔒Estimated value
Upgrade to see
Turnover
year to Apr 2025
Net worth
book net assets
Opportunity
63/100
Worth a look
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Research and experimental development on biotechnology
Sector: Professional, scientific & technical
Investor take
Pass (distressed without resilience)
Distressed active trading company — structural issues outweigh the discount.

Opportunity 63/100 (worth a look), bankability 65/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Resolve: Confirmation statement overdue. Annual confirmation statement not filed on time. Required statutory filing — overdue is a strong discipline signal. Most likely exit: share sale to pe / searcher (58/100).

Data confidence

Overall: medium (78/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
1 officers (1 active, 1 linked, 1 with DOB)
90
Ownership & PSC
1 active PSC(s) of 1 total, 1 with control declared
90
Director network
Network not yet resolved
30
Filing history
15 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
63/100Worth a look
PassWatchWorth a lookStrongExceptional 

Mixed signal. Worth opening the full target workup before deciding to pursue.

Business quality
55
Adequate — check latest filings for context.
Acquirability
50
Some acquirability indicators.
Risk profile
67
Some moderate concerns — review flags.
Signal strength
90
Good data coverage for analysis.

Key financials

2 years extracted from filed iXBRL accounts
Cash
Net Worth
Current Assets
Current Liabilities
£0£0£0£0£0£0Apr 2024Apr 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 102
Metric2025-04-302024-04-30

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

Recent activity

Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
1
filing
  • 1 accounts
Counts from Companies House filing history.
Corporate timeline (10 events)Click to expand
  1. 2026-01-12
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  2. 2024-11-20
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  3. 2024-01-30
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  4. 2022-12-12
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  5. 2022-01-31
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  6. 2021-01-22
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  7. 2019-12-18
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  8. 2018-04-19
    🏢
    Company incorporated
    As ALMRO CLINICAL RESEARCH SOLUTIONS LTD
  9. 2018-04-19
    MROUE, Aleksandra appointed
    director
  10. 2018-04-19
    📄
    incorporation-company
    incorporation · NEWINC

Owner dependency

80/100
Critical — business is the founder

The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.

FACTORS
  • +Sole director: Only one active director — all governance concentrated on one person.
  • +No director turnover: Company is 8 years old with no director changes — suggests a very tight-knit founder team never broadened.

Succession & seller-readiness

45/100
Moderate signal

Some succession indicators present. Worth watching; approach if sector/strategy fits.

SIGNALS
  • primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.

Red flags

1 high ·
Confirmation statement overdue
high

Annual confirmation statement not filed on time. Required statutory filing — overdue is a strong discipline signal.

Evidence: Next due: 2026-04-25

Shareholders & ownership

1 active beneficial owner · dominant holder ≥75%
NameSharesVoting rightsNature of controlNotified
Ms Aleksandra Mroue
Individual · Polish · DOB 12/1976 · age 50
75100%
75–100%board control75-100% shares · 75-100% voting · board control19/04/2018

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Professional services · NW postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
A.M.C. SERVICES (UK) LIMITED
08941422 · est 2014 · no financials extracted
12y
ALICE LESTER CONSULTING LTD
17096333 · est 2026 · no financials extracted
ALLOW CONSULTING LIMITED
11071711 · est 2017 · no financials extracted
8y
ALLSORTS ADVISORY LTD
15152004 · est 2023 · no financials extracted
2y
ALPHA ACCOUNTANCY (UK) LTD
05432515 · est 2005 · no financials extracted
20y
ALPHA GOVERNANCE PARTNERS LIMITED
09645344 · est 2015 · no financials extracted
10y
ALPHA RESOURCE CONSULTING LTD
09998362 · est 2016 · no financials extracted
10y
ALPHANUMERIC ACCOUNTANTS LIMITED
05395196 · est 2005 · no financials extracted
21y
ALRIDHA FOUNDATION
07248420 · est 2010 · no financials extracted
15y
ALTANA RECRUITMENT LTD
10208213 · est 2016 · no financials extracted
9y
ALTERNATIVE INVESTMENTS CONSULTING LTD
12292627 · est 2019 · no financials extracted
6y
ALTIOS INTERNATIONAL UK LIMITED
03202078 · est 1996 · no financials extracted
29y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2018-04-19
Jurisdictionengland-wales
Primary SIC72110 — Research and experimental development on biotechnology

Registered office

62 Camden Road Camden Town
London
NW1 9DR
United Kingdom

Filing status

Accounts
Next due: 2027-01-31
Last made up to: 2025-04-30
Confirmation statement
Next due: 2026-04-25OVERDUE
Last: 2025-04-11

Officers (1 active · 0 resigned)

MROUE, Aleksandra
director · ~50y · appointed 2018-04-19
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Recent filings (15 total)

accounts-with-accounts-type-dormant
accounts · AA
2026-01-12
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-05-17
accounts-with-accounts-type-dormant
accounts · AA
2024-11-20
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-04-29
accounts-with-accounts-type-dormant
accounts · AA
2024-01-30
confirmation-statement-with-no-updates
confirmation-statement · CS01
2023-04-11
accounts-with-accounts-type-dormant
accounts · AA
2022-12-12
confirmation-statement-with-no-updates
confirmation-statement · CS01
2022-05-10
accounts-with-accounts-type-micro-entity
accounts · AA
2022-01-31
confirmation-statement-with-no-updates
confirmation-statement · CS01
2021-04-29
accounts-with-accounts-type-total-exemption-full
accounts · AA
2021-01-22
confirmation-statement-with-no-updates
confirmation-statement · CS01
2020-05-15
accounts-with-accounts-type-total-exemption-full
accounts · AA
2019-12-18
confirmation-statement-with-no-updates
confirmation-statement · CS01
2019-05-20
incorporation-company
incorporation · NEWINC
2018-04-19